Related Experiment Video
Updated: Oct 12, 2025

06:07
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.8K
NAD+ Metabolism and Diseases with Motor Dysfunction
Samuel Lundt1,2, Shinghua Ding1,3
1Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211, USA.
Genes
|November 27, 2021
Summary
Nicotinamide adenine dinucleotide (NAD+) metabolism is crucial for cellular functions. Research explores NAD+
Area of Science:
- Neuroscience
- Biochemistry
- Metabolomics
Background:
- Neurodegenerative diseases cause progressive nervous system deterioration, affecting motor and cognitive functions.
- Motor neuron diseases (MNDs) and other neurodegenerative conditions like Parkinson's and Huntington's disease involve motor dysfunction.
- Nicotinamide adenine dinucleotide (NAD+) is a vital metabolite involved in energy metabolism, DNA repair, and cellular signaling.
Purpose of the Study:
- To review cellular NAD+ homeostasis, including biosynthesis and consumption pathways, with emphasis on the NAD+ salvage pathway.
- To examine current research and clinical trials investigating the role of NAD+ metabolism in neurodegenerative diseases with motor dysfunction.
Main Methods:
- Literature review of NAD+ metabolism and its connection to neurodegeneration.
- Analysis of studies focusing on NAD+ biosynthesis, salvage pathways, and consumption.
- Examination of human clinical trial data related to NAD+ and motor dysfunction in neurodegenerative diseases.
Main Results:
- The NAD+ salvage pathway is the primary source of NAD+ in mammalian cells.
- Dysregulation of NAD+ metabolism is implicated in the pathogenesis of neurodegenerative diseases.
- Emerging research and clinical trials suggest a potential therapeutic role for modulating NAD+ levels in these conditions.
Conclusions:
- Understanding NAD+ homeostasis is critical for neurodegenerative disease research.
- Targeting NAD+ metabolism, particularly the salvage pathway, may offer novel therapeutic strategies for motor neuron diseases and other neurodegenerative conditions.
- Further investigation into NAD+ 's role in neuroprotection is warranted.
Related Concept Videos
Parkinson's Disease: Overview
819
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
819
Parkinson's Disease: Treatment
440
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
440
Drugs Affecting Neurotransmitter Synthesis
1.7K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.7K
Disorders of the Nervous Tissue
1.9K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.9K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
727
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
727
Neural Regulation
40.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.5K

